CN204050019U - Hemostatic and antibacterial dressing plaster - Google Patents
Hemostatic and antibacterial dressing plaster Download PDFInfo
- Publication number
- CN204050019U CN204050019U CN201420212285.0U CN201420212285U CN204050019U CN 204050019 U CN204050019 U CN 204050019U CN 201420212285 U CN201420212285 U CN 201420212285U CN 204050019 U CN204050019 U CN 204050019U
- Authority
- CN
- China
- Prior art keywords
- layer
- antibiotic
- hemostasis
- hemostatic
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002439 hemostatic effect Effects 0.000 title claims description 26
- 230000000844 anti-bacterial effect Effects 0.000 title description 6
- 239000011505 plaster Substances 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 claims abstract description 27
- 230000023597 hemostasis Effects 0.000 claims abstract description 21
- 230000002421 anti-septic effect Effects 0.000 claims description 11
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 238000005253 cladding Methods 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 16
- 206010052428 Wound Diseases 0.000 description 14
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000012260 Accidental injury Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002942 anti-growth Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Abstract
The utility model relates to a hemostasis, antibiotic dressing subsides aims at solving the easy contaminated technical problem of current dressing subsides, including first from the layer, set up in the first layer of stanching on the layer of leaving, its characterized in that: still include the second from the layer, set up in antibiotic layer on the second from the layer, hemostasis layer and antibiotic layer bond each other, the utility model discloses a first from layer, second from hemostasis layer and antibiotic layer of cladding between the layer, enable this dressing when taking out the disinfection jar or when tearing the extranal packing, its hemostasis layer still does not receive external pollution with antibiotic layer.
Description
Technical field
This utility model relates to a kind of dressing paste, particularly relates to a kind of hemostasis, the antiseptic dressing subsides with anti-bacteria and growth of microorganism and breeding and promotion blood coagulation reaction simultaneously.
Background technology
Surgical operation comprises neurosurgery, abdominal operation, operation on vessels of heart, thoracic operation, head and operation on neck, pelvic surgery and the hands such as skin and subcutaneous tissue art; Operation process or have an accident injury time, blood vessel can bleed because of breaking in a large number; When blood loss is no more than 10% of the total blood volume in human body, health can pass through self regulation, just can recover very soon; If blood loss reaches 20% of the total blood volume of health, pulse will be there will be and accelerate, the symptoms such as blood pressure drops; If the blood run off at short notice reaches 30% of the total blood of whole body or more, just may threat to life.
Nowadays, traditional hemostasis processing mode, such as artificial pressure hemostasis, burn process or wound stitching etc., all quite consuming time, and may not necessarily effectively stop blooding.In recent years, the hemorrhage of some local was developed for controlling because operation or traumatic hemorrhage; This hemorrhage just promotes blood coagulation reaction touching bleeding wounds face, forms thrombosis rapidly, stops hemorrhage situation.It can thus be appreciated that hemostatic technique by the apparatus haemostatic measures that the past is simple, develops into biological hemostatic technology.Therefore, hemostasis is the pith of clinical treatment, and effective hemostasis is then the necessary guarantee to patient vitals's safety.And have time several years using dressing as the application of local hemostasis wound.
The dressing crossed through sterilization treatment, to human external trauma care, as incised wound, scratch, surgical incision, ulcer or burn etc., all in these site of injury mulchings or must be wrapped up, to prevent from being infected by extraneous antibacterial usually by medical institutions; And for example, when skin damage, although wound drug treating, wound still can with medicated clothing or extraneous contact, namely can be collided or be infected with the dust in air or antibacterial because of carelessness, cause the deterioration of wound.Therefore in order to wound infection will be avoided, on wound process, usually can cover or wrap up one through the dressing of sterilization processing as completely cutting off.But, the dressing that current general curative mechanism uses is most still for pressing from both sides the cotton pad made by the Cotton Gossypii after sterilization treatment between gauze or two layers of gauze, this type of dressing meeting sepage bleeds back, corrode periwound skin causes infection, or the sepage absorbed is volatilized and makes gauze hardening, and damage the phenomenons such as wound; Especially this dressing is normally left concentratedly in disinfection tank, but the regular unlatching of disinfection tank, covers the dressing of internal storage still can be made to be subject to outside contamination; If use packaging bags dressing, after taking packaging bag apart, namely dressing expose in atmosphere and easily contaminated completely.
Summary of the invention
The purpose of this utility model is to overcome the deficiencies in the prior art, adapts to reality need, provides a kind of hemostasis, antiseptic dressing subsides, is intended to solve current dressing paste and easily causes wound infection or injury, and easy contaminated technical problem.
In order to realize the purpose of this utility model, the technical scheme that this utility model adopts is:
A kind of hemostasis of design, antiseptic dressing are pasted, and comprise first from shape layer, second from shape layer, be arranged at described first from the hemostatic layer on shape layer, be arranged at described second from the antibiotic layer on shape layer, described hemostatic layer and antibiotic layer are bonded to each other.
Described hemostatic layer, antibiotic layer location swap.
Described first makes by mould release membrance from shape layer, second from shape layer.
Described hemostatic layer, antibiotic layer are made by sodium alginate.
The beneficial effects of the utility model are:
1. this hemostasis, antiseptic dressing are pasted in use by first, second being removed from shape layer, just promote blood coagulation reaction by hemostatic layer, and simultaneously antibiotic layer can anti-bacteria and microbial growth and breeding, and accelerated in wounds is restored.
2. by first from shape layer, second from coated hemostatic layer and antibiotic layer between shape layer, can make this dressing when taking out disinfection tank or when removing outer package, its hemostatic layer and antibiotic layer are not still subject to outside contamination.
Accompanying drawing explanation
Fig. 1 is one of this utility model structural profile schematic diagram;
Fig. 2 is this utility model structural profile schematic diagram two;
Fig. 3 is this utility model using state schematic diagram;
In figure: 1. first from shape layer; 2. hemostatic layer; 3. antibiotic layer; 4. second from shape layer.
Detailed description of the invention
Below in conjunction with drawings and Examples, this utility model is further illustrated:
Embodiment 1: a kind of hemostasis, antiseptic dressing are pasted, see Fig. 1, Fig. 3, comprise from bottom to top set gradually first from shape layer 1, hemostatic layer 2, antibiotic layer 3 and second from shape layer 4; Described first makes by mould release membrance from shape layer 1, second from shape layer 2.The manufacturing process that this hemostasis, antiseptic dressing are pasted be first first from this hemostatic layer 2 of molding on shape layer 1, simultaneously second from this antibiotic layer 3 of molding on shape layer 4, then by this hemostatic layer 2, antibiotic layer 3 is corresponding combines with this again, can form this hemostasis, antiseptic dressing pastes.During use, directly remove first from shape layer 4 from shape layer 1, second, and hemostatic layer is attached at wound, the blood coagulation of wound is so just promoted by this hemostatic layer 2, reach the effect of hemostasis, this antibiotic layer 3 anti-bacteria and microbial growth and breeding, avoid wound to be infected, with the recovery of accelerated in wounds simultaneously.
Above-mentioned antibiotic layer, hemostatic layer are made by sodium alginate, in described antibiotic layer also can by sorbitol, etc. other conventional antibiotic substance, in described hemostatic layer also can by spherical chitosan, etc. other common hemostatic substance.
Embodiment 2: see Fig. 2, Fig. 3, do not stating with embodiment 1 something in common, difference is, described hemostatic layer 2 exchange with the order that arranges of antibiotic layer 3, namely first first from molding antibiotic layer 3 on shape layer 1, while second from molding hemostatic layer 2 on shape layer 4, combine corresponding with antibiotic layer 3 for hemostatic layer 2 again, namely form structure as shown in Figure 2.
Cited embodiment is only that this utility model part embodiment illustrates above; and be not used to the core concept limiting this utility model; those of ordinary skill in the art; very easily according to above-described embodiment; understand spirit of the present utility model; and make different amplifications and change, but only otherwise depart from spirit of the present utility model, all in protection domain of the present utility model.
Claims (3)
1. a hemostasis, antiseptic dressing are pasted, and comprise first from shape layer, be arranged at described first from the hemostatic layer on shape layer, it is characterized in that: also comprise second from shape layer, be arranged at described second from the antibiotic layer on shape layer, described hemostatic layer and antibiotic layer are bonded to each other; Described hemostatic layer, antibiotic layer are made by sodium alginate.
2. hemostasis as claimed in claim 1, antiseptic dressing paste, and it is characterized in that: described hemostatic layer, antibiotic layer location swap.
3. hemostasis as claimed in claim 1, antiseptic dressing paste, and it is characterized in that: described first makes by mould release membrance from shape layer, second from shape layer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102209941U TWM462604U (en) | 2013-05-28 | 2013-05-28 | Structure of bleeding-stopping and antimicrobial wound dressings |
| TW102209941 | 2013-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204050019U true CN204050019U (en) | 2014-12-31 |
Family
ID=49771781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420212285.0U Expired - Fee Related CN204050019U (en) | 2013-05-28 | 2014-04-29 | Hemostatic and antibacterial dressing plaster |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN204050019U (en) |
| TW (1) | TWM462604U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105495805A (en) * | 2015-12-21 | 2016-04-20 | 常熟市立新无纺布织造有限公司 | Alginate hemostatic pad |
-
2013
- 2013-05-28 TW TW102209941U patent/TWM462604U/en not_active IP Right Cessation
-
2014
- 2014-04-29 CN CN201420212285.0U patent/CN204050019U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105495805A (en) * | 2015-12-21 | 2016-04-20 | 常熟市立新无纺布织造有限公司 | Alginate hemostatic pad |
Also Published As
| Publication number | Publication date |
|---|---|
| TWM462604U (en) | 2013-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Daunton et al. | A history of materials and practices for wound management | |
| CN204016935U (en) | A kind of medical bio magnetic dressing pastes | |
| CN107412842B (en) | Preparation method of alginate wound dressing with thrombin | |
| CN204050019U (en) | Hemostatic and antibacterial dressing plaster | |
| CN204274553U (en) | A kind of transfusion compression band | |
| CN211433138U (en) | Emergency department hemostasis bandage care implement | |
| CN202236501U (en) | Honey dressing for exchanging medicament of infective wound | |
| CN204468438U (en) | For the permanent magnetism navel protective cord of Neonatal umbilical part nursing | |
| Liden et al. | Hypochlorous acid: Its multiple uses for wound care | |
| CN205359798U (en) | Woundplast that contains oxidized regenerated cellulose | |
| CN202173517U (en) | Aseptic dressing spicule plaster | |
| CN218420218U (en) | Portable moist applying ointment or plaster | |
| CN203763542U (en) | Collagen bandage | |
| CN103892962A (en) | Nanometer type sterilization and bleeding stopping operation towel | |
| CN204092092U (en) | Novel hemostatic dressing plaster | |
| CN202235920U (en) | Postoperative incision nursing device | |
| CN202336082U (en) | Chitosan disinfectant dressing patch | |
| CN203208213U (en) | Wound suturing adhesive plaster | |
| CN201987751U (en) | Nylon binding net buckle for urinary surgery | |
| CN211911972U (en) | Dental postoperative hemostatic gauze | |
| CN210144862U (en) | Adhesive bandage containing Aloe and tea | |
| CN203802669U (en) | Wet tissue for medical use | |
| CN215020474U (en) | Burn branch of academic or vocational study is with aseptic applying ointment or plaster that has disinfection function | |
| CN217040502U (en) | Prevent special application of internal fistula infection | |
| CN111956859B (en) | Antibacterial hemostatic band-aid containing traditional Chinese medicine components and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141231 Termination date: 20180429 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |